El Ensayo ha Contado con 585 Participantes Repartidos en 143 Hospitales de los Siguientes Paises :
EEUU , CHINA , RUSIA , ISRAEL , AUSTRALIA , NUEVA ZELANDA , POLONIA , SUD AFRICA , UK Y SUIZA .
Study Status :
Record Verification : July 2018
Overall Status : Active, not recruiting
Study Start : October 16, 2013
Primary Completion : January 18, 2018 [Actual]
Study Completion : December 31, 2018 [Anticipated]
Sponsor and Responsible Party : Janssen Research & Development, LLC .
Collaborators : PharmaMar .
Oversight
U.S. FDA-regulated Drug:
U.S. FDA-regulated Device:
Data Monitoring : Yes